Back to News
Market Impact: 0.1
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Source: Business Wire
Healthcare & Biotech
CEL-SCI has been invited to deliver a keynote address on its Multikine therapy at the 6th World Congress on Otology, Rhinology and Laryngology. The announcement indicates scientific and industry visibility for Multikine but provides no clinical data, regulatory update, financial metrics, or commercial milestone.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
CVM0.35
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Beta Bionics prices $150M public offering at $17.25/share
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- Why is Vera Therapeutics stock reversing its premarket gains?
- H.C. Wainwright raises Scholar Rock stock price target on FDA approval